×
Choose Speciality

EXPLORE!

LOGIN

By signing up or signing in to eMediNexus, you consent to eMediNexus collecting and using your personal data in accordance with our Privacy Policy. We are committed to safeguarding your information and ensuring the highest standards of data protection. Your trust and privacy are of utmost importance to us.

Leading pharma companies announce branded versions of molnupiravir in India

  110 Views

eMediNexus    21 January 2022

The DCGI based on the review of clinical data of Molnupiravir, has given restricted emergency use authorization for the drug to treat Covid-19 in adults with SpO2 > 93% and who have high risk of disease progression. 

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.